澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

NEUREN PHARMACEUTICALS LTD

13.510

+0.2001.50%

成交量：60.20萬

成交額：805.66萬

市值：17.11億

市盈率：11.77

高：13.560

開：13.320

低：13.040

收：13.310

52周最高：22.985

52周最低：8.610

股本：1.27億

流通股本：1.08億

量比：0.69

換手率：0.56%

股息：- -

股息率：- -

每股收益(TTM):1.148

每股收益(LYR):1.086

淨資產收益率：54.96%

總資產收益率：41.13%

市淨率：5.29

市盈率(LYR):12.44

資料載入中...

總覽公司新聞資訊公告

概念

醫藥生物股+1.74%

資金流向

資金流入：

資金流出：

新聞資訊

BUZZ-雷特（Rett）藥物在歐洲市場受挫，傑富瑞下調澳大利亞 Neuren 公司的目標價和盈利預期

Neuren製藥公司就缺氧缺血性腦病新藥臨牀試驗申請計劃獲監管反饋

BUZZ-澳大利亞 Neuren 公司雷特綜合症治療藥物申請因歐洲監管機構受挫而下挫

Neuren Pharmaceuticals獲歐洲藥品管理局人用藥品委員會通知

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/NEU.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NEU.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NEU.AU\",,,,,undefined,":{"symbol":"NEU.AU","market":"AU","secType":"STK","nameCN":"NEUREN PHARMACEUTICALS LTD","latestPrice":13.51,"timestamp":1770700320000,"preClose":13.31,"halted":0,"volume":601984,"delay":0,"changeRate":0.015026296018031501,"nameEN":"NEUREN PHARMACEUTICALS LTD","floatShares":108394581,"shares":126639526,"eps":1.147709,"marketStatus":"已收盤","change":0.2,"latestTime":"02-10 16:12:00 AEDT","open":13.32,"high":13.56,"low":13.04,"amount":8056584,"amplitude":0.039068,"askPrice":13.88,"askSize":385,"bidPrice":13.51,"bidSize":122,"shortable":3,"etf":0,"ttmEps":1.147709,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1770764400000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":13.31,"openAndCloseTimeList":[[1770678000000,1770699600000]],"volumeRatio":0.686544,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NEU.AU\",,,,,undefined,":{"symbol":"NEU.AU","floatShares":108394581,"roa":"41.13%","roe":"54.96%","lyrEps":1.086099,"volumeRatio":0.686544,"shares":126639526,"dividePrice":0,"high":13.56,"amplitude":0.039068,"preClose":13.31,"low":13.04,"week52Low":8.61,"pbRate":"5.29","psRate":"7.82","week52High":22.985,"institutionHeld":0,"latestPrice":13.51,"committee":-0.518738,"eps":1.147709,"divideRate":0,"volume":601984,"delay":0,"ttmEps":1.147709,"open":13.32,"prevYearClose":18.61,"prevWeekClose":12.52,"prevMonthClose":16.69,"prevQuarterClose":18.61,"fiveDayClose":14.63,"twentyDayClose":19.32,"sixtyDayClose":18.64},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NEU.AU\",params:#limit:5,,,undefined,":[{"date":"2025-02-28","symbol":"NEU.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740697200000,"name":null,"time":"","dateTimestamp":1740661200000,"actualEps":null},{"market":"AU","date":"2024-02-29","symbol":"NEU.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1709125200000,"reportTimeType":"","actualEps":null},{"date":"2023-08-28","symbol":"NEU.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693180800000,"name":null,"time":"","dateTimestamp":1693144800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NEU.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NEU.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609958989","title":"BUZZ-雷特（Rett）藥物在歐洲市場受挫，傑富瑞下調澳大利亞 Neuren 公司的目標價和盈利預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2609958989","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609958989?lang=zh_tw&edition=fundamental","pubTime":"2026-02-06 04:06","pubTimestamp":1770321964,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nL4T3Z12IJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065170008.USD","LU2065171311.SGD","NEU.AU","BK7508","ACAD","BK4139","LU2065169927.USD","LU2065171402.SGD","BK7096"],"gpt_icon":0},{"id":"1152637192","title":"Neuren製藥公司就缺氧缺血性腦病新藥臨牀試驗申請計劃獲監管反饋","url":"https://stock-news.laohu8.com/highlight/detail?id=1152637192","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152637192?lang=zh_tw&edition=fundamental","pubTime":"2026-02-04 14:11","pubTimestamp":1770185472,"startTime":"0","endTime":"0","summary":"Neuren Pharmaceuticals Ltd（NEU.AU）近日宣布，已收到关于其针对缺氧缺血性脑病（HIE）的新药临床试验（IND）申请计划的相关反馈意见。\n该反馈涉及公司计划向监管机构提交的IND申请的具体方案，标志着其在HIE治疗药物研发进程中迈出重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7096","NEU.AU"],"gpt_icon":0},{"id":"2608196148","title":"BUZZ-澳大利亞 Neuren 公司雷特綜合症治療藥物申請因歐洲監管機構受挫而下挫","url":"https://stock-news.laohu8.com/highlight/detail?id=2608196148","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608196148?lang=zh_tw&edition=fundamental","pubTime":"2026-02-03 08:02","pubTimestamp":1770076936,"startTime":"0","endTime":"0","summary":"2月3日 - ** 生物制药公司Neuren Pharmaceuticals NEU.AX股价暴跌22.1%至12.660澳元，创下2018年8月初以来最大盘中跌幅。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nL4S3YZ00C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","LU2065170008.USD","NEU.AU","BK7096","LU2065171402.SGD","BK4139","LU2065169927.USD","LU2065171311.SGD","ACAD"],"gpt_icon":0},{"id":"1122324471","title":"Neuren Pharmaceuticals獲歐洲藥品管理局人用藥品委員會通知","url":"https://stock-news.laohu8.com/highlight/detail?id=1122324471","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122324471?lang=zh_tw&edition=fundamental","pubTime":"2026-02-03 06:42","pubTimestamp":1770072164,"startTime":"0","endTime":"0","summary":"Neuren Pharmaceuticals Ltd (NEU.AU) 已收到欧洲药品管理局人用药品委员会（CHMP）的正式通知。该通知涉及公司相关药品的审评进展，标志着其在欧洲监管审批流程中的重要节点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","NEU.AU","BK7508"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NEU.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"醫藥生物股","bkCode":"BK7508","id":"package_au_concept_yyswg","changeRate":0.017447}]}}